-
2
-
-
0027456597
-
Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
-
Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA. 1993;269:2246-2248.
-
(1993)
JAMA
, vol.269
, pp. 2246-2248
-
-
Pastuszak, A.1
Schick-Boschetto, B.2
Zuber, C.3
-
3
-
-
0029795224
-
Birth outcomes in pregnant women taking fluoxetine
-
Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335:1010-1015.
-
(1996)
N Engl J Med
, vol.335
, pp. 1010-1015
-
-
Chambers, C.D.1
Johnson, K.A.2
Dick, L.M.3
-
4
-
-
0031022182
-
Neurodevelopment of children exposed in utero to antidepressant drugs
-
Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336:258-262.
-
(1997)
N Engl J Med
, vol.336
, pp. 258-262
-
-
Nulman, I.1
Rovet, J.2
Stewart, D.E.3
-
5
-
-
4944249178
-
Psychopharmacology during pregnancy and lactation
-
Schatzberg AF, Nemeroff CB, eds. Washington, DC: American Psychiatric Publishing
-
Newport DJ, Fisher A, Graybeal S, Stowe ZN. Psychopharmacology during pregnancy and lactation. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Publishing Textbook of Psychopharmacology. 3rd ed. Washington, DC: American Psychiatric Publishing; 2004:1109-1146.
-
(2004)
The American Psychiatric Publishing Textbook of Psychopharmacology. 3rd Ed.
, pp. 1109-1146
-
-
Newport, D.J.1
Fisher, A.2
Graybeal, S.3
Stowe, Z.N.4
-
6
-
-
32144456450
-
-
US Food and Drug Administration. December 8, Available at. Accessed July 14, 2006
-
US Food and Drug Administration. FDA public health advisory: paroxetine. December 8, 2005. Available at: http://www.fda.gov/cder/drug/advisory/ paroxetine200512.htm. Accessed July 14, 2006.
-
(2005)
FDA Public Health Advisory: Paroxetine
-
-
-
7
-
-
32144436098
-
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
-
Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579-587.
-
(2006)
N Engl J Med
, vol.354
, pp. 579-587
-
-
Chambers, C.D.1
Hernandez-Diaz, S.2
Van Marter, L.J.3
-
8
-
-
32244441984
-
Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants
-
Levinson-Castiel R, Merlob P, Linder N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160:173-176.
-
(2006)
Arch Pediatr Adolesc Med
, vol.160
, pp. 173-176
-
-
Levinson-Castiel, R.1
Merlob, P.2
Linder, N.3
-
9
-
-
33845800751
-
Paroxetine in pregnancy? FDA advisory flunks as evidence-based medicine, for
-
Wulsin L, Ignatowski M. Paroxetine in pregnancy? FDA advisory flunks as evidence-based medicine, for Psychiatry. 2006;5:45-51.
-
(2006)
Psychiatry
, vol.5
, pp. 45-51
-
-
Wulsin, L.1
Ignatowski, M.2
-
10
-
-
32144442172
-
Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy
-
Mills JL. Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy. N Engl J Med. 2006;354:636-638.
-
(2006)
N Engl J Med
, vol.354
, pp. 636-638
-
-
Mills, J.L.1
-
12
-
-
33845739176
-
SSRI use during pregnancy. Do antidepressants' benefits outweigh the risks?
-
Hasser C, Brizendine L, Spielvogel A. SSRI use during pregnancy. Do antidepressants' benefits outweigh the risks? Curr Psychiatry 2006;5:31-40.
-
(2006)
Curr Psychiatry
, vol.5
, pp. 31-40
-
-
Hasser, C.1
Brizendine, L.2
Spielvogel, A.3
-
13
-
-
32044455762
-
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment
-
Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507.
-
(2006)
JAMA
, vol.295
, pp. 499-507
-
-
Cohen, L.S.1
Altshuler, L.L.2
Harlow, B.L.3
|